Nia Health develops indication-specific medical software and Digital Therapeutics (DTx) to support patients with chronic skin and allergy conditions. Using a platform-based approach, the company delivers end-to-end, clinically validated solutions that combine patient engagement, gamification and machine learning to enable personalized care and improve health outcomes.

Nia Health's product portfolio includes CE-approved medical device apps (for eczema, psoriasis and acne) and platform services for remote patient monitoring and digital trial support. The company emphasizes data security and regulatory compliance (ISO 27001, GDPR) and works with payers, providers and pharma partners to enable reimbursement and scale. Nia Health aims to reduce system burden by providing clinically-backed, patient-centric digital interventions and real-world evidence to support R&D and clinical decision-making.